Oral lesions with immunohistochemical evidence of Sars‐CoV‐2 in swab‐negative post‐COVID syndrome
Objectives Growing evidence exists about post‐COVID condition/syndrome as sequelae of Sars‐CoV‐2 infection in healed patients, possibly involving the lungs, brain, kidney, cardiovascular and neuromuscular system, as well the persistency of taste dysfunction. Such symptoms develop during or after inf...
Gespeichert in:
Veröffentlicht in: | Oral diseases 2024-04, Vol.30 (3), p.1264-1272 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1272 |
---|---|
container_issue | 3 |
container_start_page | 1264 |
container_title | Oral diseases |
container_volume | 30 |
creator | Limongelli, Luisa Favia, Gianfranco Maiorano, Eugenio D'Amati, Antonio Pispero, Alberto Ingravallo, Giuseppe Barile, Giuseppe Tempesta, Angela Dell'Olio, Fabio Siciliani, Rosaria Arianna Capodiferro, Saverio |
description | Objectives
Growing evidence exists about post‐COVID condition/syndrome as sequelae of Sars‐CoV‐2 infection in healed patients, possibly involving the lungs, brain, kidney, cardiovascular and neuromuscular system, as well the persistency of taste dysfunction. Such symptoms develop during or after infection and continue for more than 12 weeks with pathogenesis related to virus persistency but variable by organs or systems.
Materials and Methods
We recently observed six patients recovered from COVID‐19 and with negative RT‐PCR testing, showing oral mucosa lesions (mainly ulcers) overlapping those occurring in the acute phase, persisting up to 20 days and thus needing a biopsy with histological investigation and spike protein evaluation by immunohistochemistry.
Results
We found epithelial ulceration, inflammatory infiltrate, vessels with increased diameter and flattened endothelium but no thrombi formation; also, we found a weak epithelial SARS‐CoV‐2 positivity limited to the basal/spinosum layers, progressively decreasing toward the periphery, and the intraepithelial lymphomonocytes, endothelium, and perivascular pericytes too.
Conclusions
Our findings provide evidence that SARS‐CoV‐2 can persist, as for other organs/systems, also in the oral epithelium/mucosa after the acute phase and can be responsible for lesions, although by a pathogenetic mechanism that should be better defined but certainly referable as the oral mucosa counterpart of post‐COVID syndrome. |
doi_str_mv | 10.1111/odi.14532 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2775951743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3054015142</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3882-b8b7a6241073c3c1937f4b85992168d9b54e6a49dd7dbc811a5eda4700c0e15b3</originalsourceid><addsrcrecordid>eNp10LtOHDEUBmArShQuoeAFkKU0oRjwdTxToiWElZC2gCA6y2OfZY1mxos9w2o7HiHPyJNgWEKBhAv7FJ9--fwI7VNyRPM5Ds4fUSE5-4K2aUloQSomv-aZS1FIxm-20E5Kd4RQVXP2HW3xUinJSraN_CyaFreQfOgTXvlhgX3XjX1Y-DQEu4DO2wzgwTvoLeAwx5cmpqfHf5NwnW-GfY_TyjR57uHWDP4B8DKk4UXMrqenOK17F0MHP9C3uWkT7L29u-jv2e-ryXlxMfsznZxcFJZXFSuaqlGmZIISxS23tOZqLppK1jWjZeXqRgoojaidU66xFaVGgjNCEWIJUNnwXfRrk7uM4X6ENOjOJwtta3oIY9Isr15LqgTP9OcHehfG2OffaU6kIFRSwbI63CgbQ0oR5noZfWfiWlOiX_rXuX_92n-2B2-JY9OBe5f_C8_geANWvoX150l6djrdRD4DN3eSLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054015142</pqid></control><display><type>article</type><title>Oral lesions with immunohistochemical evidence of Sars‐CoV‐2 in swab‐negative post‐COVID syndrome</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Limongelli, Luisa ; Favia, Gianfranco ; Maiorano, Eugenio ; D'Amati, Antonio ; Pispero, Alberto ; Ingravallo, Giuseppe ; Barile, Giuseppe ; Tempesta, Angela ; Dell'Olio, Fabio ; Siciliani, Rosaria Arianna ; Capodiferro, Saverio</creator><creatorcontrib>Limongelli, Luisa ; Favia, Gianfranco ; Maiorano, Eugenio ; D'Amati, Antonio ; Pispero, Alberto ; Ingravallo, Giuseppe ; Barile, Giuseppe ; Tempesta, Angela ; Dell'Olio, Fabio ; Siciliani, Rosaria Arianna ; Capodiferro, Saverio</creatorcontrib><description>Objectives
Growing evidence exists about post‐COVID condition/syndrome as sequelae of Sars‐CoV‐2 infection in healed patients, possibly involving the lungs, brain, kidney, cardiovascular and neuromuscular system, as well the persistency of taste dysfunction. Such symptoms develop during or after infection and continue for more than 12 weeks with pathogenesis related to virus persistency but variable by organs or systems.
Materials and Methods
We recently observed six patients recovered from COVID‐19 and with negative RT‐PCR testing, showing oral mucosa lesions (mainly ulcers) overlapping those occurring in the acute phase, persisting up to 20 days and thus needing a biopsy with histological investigation and spike protein evaluation by immunohistochemistry.
Results
We found epithelial ulceration, inflammatory infiltrate, vessels with increased diameter and flattened endothelium but no thrombi formation; also, we found a weak epithelial SARS‐CoV‐2 positivity limited to the basal/spinosum layers, progressively decreasing toward the periphery, and the intraepithelial lymphomonocytes, endothelium, and perivascular pericytes too.
Conclusions
Our findings provide evidence that SARS‐CoV‐2 can persist, as for other organs/systems, also in the oral epithelium/mucosa after the acute phase and can be responsible for lesions, although by a pathogenetic mechanism that should be better defined but certainly referable as the oral mucosa counterpart of post‐COVID syndrome.</description><identifier>ISSN: 1354-523X</identifier><identifier>ISSN: 1601-0825</identifier><identifier>EISSN: 1601-0825</identifier><identifier>DOI: 10.1111/odi.14532</identifier><identifier>PMID: 36775262</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Biopsy ; Cardiovascular disease ; Complications ; COVID-19 ; COVID-19 - complications ; COVID-19 - pathology ; Endothelium ; Epithelium ; Female ; Humans ; Immunohistochemistry ; Infections ; Inflammation ; Lesions ; Male ; Middle Aged ; Mouth Mucosa - pathology ; Mouth Mucosa - virology ; Mucosa ; negative RT‐PCR test ; Neuromuscular system ; oral mucosa lesions ; Oral Ulcer - pathology ; Oral Ulcer - virology ; Pathogenesis ; Pericytes ; Post-Acute COVID-19 Syndrome ; post‐COVID syndrome ; SARS-CoV-2 ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Spike protein ; Ulcers</subject><ispartof>Oral diseases, 2024-04, Vol.30 (3), p.1264-1272</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC.</rights><rights>2023 The Authors. Oral Diseases published by Wiley Periodicals LLC.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3882-b8b7a6241073c3c1937f4b85992168d9b54e6a49dd7dbc811a5eda4700c0e15b3</citedby><cites>FETCH-LOGICAL-c3882-b8b7a6241073c3c1937f4b85992168d9b54e6a49dd7dbc811a5eda4700c0e15b3</cites><orcidid>0000-0003-4506-6292 ; 0000-0002-0472-5338 ; 0000-0002-4810-1201 ; 0000-0002-4012-0782</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fodi.14532$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fodi.14532$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36775262$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Limongelli, Luisa</creatorcontrib><creatorcontrib>Favia, Gianfranco</creatorcontrib><creatorcontrib>Maiorano, Eugenio</creatorcontrib><creatorcontrib>D'Amati, Antonio</creatorcontrib><creatorcontrib>Pispero, Alberto</creatorcontrib><creatorcontrib>Ingravallo, Giuseppe</creatorcontrib><creatorcontrib>Barile, Giuseppe</creatorcontrib><creatorcontrib>Tempesta, Angela</creatorcontrib><creatorcontrib>Dell'Olio, Fabio</creatorcontrib><creatorcontrib>Siciliani, Rosaria Arianna</creatorcontrib><creatorcontrib>Capodiferro, Saverio</creatorcontrib><title>Oral lesions with immunohistochemical evidence of Sars‐CoV‐2 in swab‐negative post‐COVID syndrome</title><title>Oral diseases</title><addtitle>Oral Dis</addtitle><description>Objectives
Growing evidence exists about post‐COVID condition/syndrome as sequelae of Sars‐CoV‐2 infection in healed patients, possibly involving the lungs, brain, kidney, cardiovascular and neuromuscular system, as well the persistency of taste dysfunction. Such symptoms develop during or after infection and continue for more than 12 weeks with pathogenesis related to virus persistency but variable by organs or systems.
Materials and Methods
We recently observed six patients recovered from COVID‐19 and with negative RT‐PCR testing, showing oral mucosa lesions (mainly ulcers) overlapping those occurring in the acute phase, persisting up to 20 days and thus needing a biopsy with histological investigation and spike protein evaluation by immunohistochemistry.
Results
We found epithelial ulceration, inflammatory infiltrate, vessels with increased diameter and flattened endothelium but no thrombi formation; also, we found a weak epithelial SARS‐CoV‐2 positivity limited to the basal/spinosum layers, progressively decreasing toward the periphery, and the intraepithelial lymphomonocytes, endothelium, and perivascular pericytes too.
Conclusions
Our findings provide evidence that SARS‐CoV‐2 can persist, as for other organs/systems, also in the oral epithelium/mucosa after the acute phase and can be responsible for lesions, although by a pathogenetic mechanism that should be better defined but certainly referable as the oral mucosa counterpart of post‐COVID syndrome.</description><subject>Adult</subject><subject>Aged</subject><subject>Biopsy</subject><subject>Cardiovascular disease</subject><subject>Complications</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - pathology</subject><subject>Endothelium</subject><subject>Epithelium</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Lesions</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mouth Mucosa - pathology</subject><subject>Mouth Mucosa - virology</subject><subject>Mucosa</subject><subject>negative RT‐PCR test</subject><subject>Neuromuscular system</subject><subject>oral mucosa lesions</subject><subject>Oral Ulcer - pathology</subject><subject>Oral Ulcer - virology</subject><subject>Pathogenesis</subject><subject>Pericytes</subject><subject>Post-Acute COVID-19 Syndrome</subject><subject>post‐COVID syndrome</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Spike protein</subject><subject>Ulcers</subject><issn>1354-523X</issn><issn>1601-0825</issn><issn>1601-0825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp10LtOHDEUBmArShQuoeAFkKU0oRjwdTxToiWElZC2gCA6y2OfZY1mxos9w2o7HiHPyJNgWEKBhAv7FJ9--fwI7VNyRPM5Ds4fUSE5-4K2aUloQSomv-aZS1FIxm-20E5Kd4RQVXP2HW3xUinJSraN_CyaFreQfOgTXvlhgX3XjX1Y-DQEu4DO2wzgwTvoLeAwx5cmpqfHf5NwnW-GfY_TyjR57uHWDP4B8DKk4UXMrqenOK17F0MHP9C3uWkT7L29u-jv2e-ryXlxMfsznZxcFJZXFSuaqlGmZIISxS23tOZqLppK1jWjZeXqRgoojaidU66xFaVGgjNCEWIJUNnwXfRrk7uM4X6ENOjOJwtta3oIY9Isr15LqgTP9OcHehfG2OffaU6kIFRSwbI63CgbQ0oR5noZfWfiWlOiX_rXuX_92n-2B2-JY9OBe5f_C8_geANWvoX150l6djrdRD4DN3eSLA</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Limongelli, Luisa</creator><creator>Favia, Gianfranco</creator><creator>Maiorano, Eugenio</creator><creator>D'Amati, Antonio</creator><creator>Pispero, Alberto</creator><creator>Ingravallo, Giuseppe</creator><creator>Barile, Giuseppe</creator><creator>Tempesta, Angela</creator><creator>Dell'Olio, Fabio</creator><creator>Siciliani, Rosaria Arianna</creator><creator>Capodiferro, Saverio</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4506-6292</orcidid><orcidid>https://orcid.org/0000-0002-0472-5338</orcidid><orcidid>https://orcid.org/0000-0002-4810-1201</orcidid><orcidid>https://orcid.org/0000-0002-4012-0782</orcidid></search><sort><creationdate>202404</creationdate><title>Oral lesions with immunohistochemical evidence of Sars‐CoV‐2 in swab‐negative post‐COVID syndrome</title><author>Limongelli, Luisa ; Favia, Gianfranco ; Maiorano, Eugenio ; D'Amati, Antonio ; Pispero, Alberto ; Ingravallo, Giuseppe ; Barile, Giuseppe ; Tempesta, Angela ; Dell'Olio, Fabio ; Siciliani, Rosaria Arianna ; Capodiferro, Saverio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3882-b8b7a6241073c3c1937f4b85992168d9b54e6a49dd7dbc811a5eda4700c0e15b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biopsy</topic><topic>Cardiovascular disease</topic><topic>Complications</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - pathology</topic><topic>Endothelium</topic><topic>Epithelium</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Lesions</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mouth Mucosa - pathology</topic><topic>Mouth Mucosa - virology</topic><topic>Mucosa</topic><topic>negative RT‐PCR test</topic><topic>Neuromuscular system</topic><topic>oral mucosa lesions</topic><topic>Oral Ulcer - pathology</topic><topic>Oral Ulcer - virology</topic><topic>Pathogenesis</topic><topic>Pericytes</topic><topic>Post-Acute COVID-19 Syndrome</topic><topic>post‐COVID syndrome</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Spike protein</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Limongelli, Luisa</creatorcontrib><creatorcontrib>Favia, Gianfranco</creatorcontrib><creatorcontrib>Maiorano, Eugenio</creatorcontrib><creatorcontrib>D'Amati, Antonio</creatorcontrib><creatorcontrib>Pispero, Alberto</creatorcontrib><creatorcontrib>Ingravallo, Giuseppe</creatorcontrib><creatorcontrib>Barile, Giuseppe</creatorcontrib><creatorcontrib>Tempesta, Angela</creatorcontrib><creatorcontrib>Dell'Olio, Fabio</creatorcontrib><creatorcontrib>Siciliani, Rosaria Arianna</creatorcontrib><creatorcontrib>Capodiferro, Saverio</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Oral diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Limongelli, Luisa</au><au>Favia, Gianfranco</au><au>Maiorano, Eugenio</au><au>D'Amati, Antonio</au><au>Pispero, Alberto</au><au>Ingravallo, Giuseppe</au><au>Barile, Giuseppe</au><au>Tempesta, Angela</au><au>Dell'Olio, Fabio</au><au>Siciliani, Rosaria Arianna</au><au>Capodiferro, Saverio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral lesions with immunohistochemical evidence of Sars‐CoV‐2 in swab‐negative post‐COVID syndrome</atitle><jtitle>Oral diseases</jtitle><addtitle>Oral Dis</addtitle><date>2024-04</date><risdate>2024</risdate><volume>30</volume><issue>3</issue><spage>1264</spage><epage>1272</epage><pages>1264-1272</pages><issn>1354-523X</issn><issn>1601-0825</issn><eissn>1601-0825</eissn><abstract>Objectives
Growing evidence exists about post‐COVID condition/syndrome as sequelae of Sars‐CoV‐2 infection in healed patients, possibly involving the lungs, brain, kidney, cardiovascular and neuromuscular system, as well the persistency of taste dysfunction. Such symptoms develop during or after infection and continue for more than 12 weeks with pathogenesis related to virus persistency but variable by organs or systems.
Materials and Methods
We recently observed six patients recovered from COVID‐19 and with negative RT‐PCR testing, showing oral mucosa lesions (mainly ulcers) overlapping those occurring in the acute phase, persisting up to 20 days and thus needing a biopsy with histological investigation and spike protein evaluation by immunohistochemistry.
Results
We found epithelial ulceration, inflammatory infiltrate, vessels with increased diameter and flattened endothelium but no thrombi formation; also, we found a weak epithelial SARS‐CoV‐2 positivity limited to the basal/spinosum layers, progressively decreasing toward the periphery, and the intraepithelial lymphomonocytes, endothelium, and perivascular pericytes too.
Conclusions
Our findings provide evidence that SARS‐CoV‐2 can persist, as for other organs/systems, also in the oral epithelium/mucosa after the acute phase and can be responsible for lesions, although by a pathogenetic mechanism that should be better defined but certainly referable as the oral mucosa counterpart of post‐COVID syndrome.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36775262</pmid><doi>10.1111/odi.14532</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-4506-6292</orcidid><orcidid>https://orcid.org/0000-0002-0472-5338</orcidid><orcidid>https://orcid.org/0000-0002-4810-1201</orcidid><orcidid>https://orcid.org/0000-0002-4012-0782</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1354-523X |
ispartof | Oral diseases, 2024-04, Vol.30 (3), p.1264-1272 |
issn | 1354-523X 1601-0825 1601-0825 |
language | eng |
recordid | cdi_proquest_miscellaneous_2775951743 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult Aged Biopsy Cardiovascular disease Complications COVID-19 COVID-19 - complications COVID-19 - pathology Endothelium Epithelium Female Humans Immunohistochemistry Infections Inflammation Lesions Male Middle Aged Mouth Mucosa - pathology Mouth Mucosa - virology Mucosa negative RT‐PCR test Neuromuscular system oral mucosa lesions Oral Ulcer - pathology Oral Ulcer - virology Pathogenesis Pericytes Post-Acute COVID-19 Syndrome post‐COVID syndrome SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Spike protein Ulcers |
title | Oral lesions with immunohistochemical evidence of Sars‐CoV‐2 in swab‐negative post‐COVID syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T12%3A11%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20lesions%20with%20immunohistochemical%20evidence%20of%20Sars%E2%80%90CoV%E2%80%902%20in%20swab%E2%80%90negative%20post%E2%80%90COVID%20syndrome&rft.jtitle=Oral%20diseases&rft.au=Limongelli,%20Luisa&rft.date=2024-04&rft.volume=30&rft.issue=3&rft.spage=1264&rft.epage=1272&rft.pages=1264-1272&rft.issn=1354-523X&rft.eissn=1601-0825&rft_id=info:doi/10.1111/odi.14532&rft_dat=%3Cproquest_cross%3E3054015142%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3054015142&rft_id=info:pmid/36775262&rfr_iscdi=true |